Scope: Hoffmann-Krueger epidemiologists had concentrated 15 types of cancer in France
A major strength of this analysis is that the forecast methodology was consistent across the 15 cancers, we used our expertise to give you the most accurate epidemiology forecast for :
Breast cancer HER 2 positive
Breast cancer HER 2 negative
HNC OC Pharyn
Lung SCL cancer
Renal cell carcinoma (RCC)
10-year patient population forecast + 5 years of historical data
Key Users: Oncology Market Research - New Product Planning - Business Development & Licensing
Oncology Market Access – Oncology Marketing leaders
Insight: Insight into the cancer strategy in France and business development activities
Transparent forecasts methodology and assumptions
Concise and comparable analysis
Key epidemiology assumptions are included to give accurate sizing of patient population, epidemiology forecast, key drivers of patient shares.
The oncology drug market is one of the fastest-growing markets in the pharmaceutical industry. The treatment of cancer has shifted away from mass market blockbuster drugs toward a more focused attack on the disease with targeted therapies.
Reasons To Buy
Hoffmann-Krueger ECF (Epidemiology Cancer Forecast) rich data set and easy-to-use tool allow you to focus on cancer subpopulation segment of interest. Hoffmann-Krueger ECF (Epidemiology Cancer Forecast) giving the opportunity to use epidemiological projections of key oncology patient population.